| A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency F Atiq, PMLA van den Bemt, FWG Leebeek, T van Gelder, J Versmissen European journal of clinical pharmacology 71, 921-929, 2015 | 98 | 2015 |
| Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders F Atiq, JL Saes, MC Punt, KPM van Galen, REG Schutgens, K Meijer, ... EClinicalMedicine 32, 2021 | 60 | 2021 |
| Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age‐related increase of VWF in von Willebrand disease F Atiq, K Meijer, J Eikenboom, K Fijnvandraat, EP Mauser‐Bunschoten, ... British journal of haematology 182 (1), 93-105, 2018 | 56 | 2018 |
| Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis ME Houwing, RL Grohssteiner, MHG Dremmen, F Atiq, WM Bramer, ... BMC medicine 18, 1-17, 2020 | 49 | 2020 |
| How I manage severe von Willebrand disease FWG Leebeek, F Atiq British journal of haematology 187 (4), 418-430, 2019 | 49 | 2019 |
| Thyroid function and cardiovascular disease: the mediating role of coagulation factors A Bano, L Chaker, MPM De Maat, F Atiq, M Kavousi, OH Franco, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3203-3212, 2019 | 24 | 2019 |
| A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib F Atiq, AEC Broers, LM Andrews, JK Doorduijn, BCP Koch, T Van Gelder, ... European journal of clinical pharmacology 72, 719-723, 2016 | 24 | 2016 |
| Endothelial dysfunction, atherosclerosis, and increase of von Willebrand factor and factor VIII: a randomized controlled trial in swine F Atiq, J Van De Wouw, O Sorop, I Heinonen, MPM De Maat, D Merkus, ... Thrombosis and Haemostasis 121 (05), 676-686, 2021 | 23 | 2021 |
| Ex vivo improvement of a von Willebrand disease type 2A phenotype using an allele-specific small-interfering RNA A de Jong, RJ Dirven, J Boender, F Atiq, SY Anvar, FWG Leebeek, ... Thrombosis and Haemostasis 120 (11), 1569-1579, 2020 | 20 | 2020 |
| von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD F Atiq, LM Schütte, AEM Looijen, J Boender, MH Cnossen, J Eikenboom, ... Blood Advances 3 (24), 4147-4154, 2019 | 20 | 2019 |
| Sports participation and physical activity in patients with von Willebrand disease F Atiq, EP Mauser‐Bunschoten, J Eikenboom, KPM van Galen, K Meijer, ... Haemophilia 25 (1), 101-108, 2019 | 20 | 2019 |
| BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease F Atiq, K Fijnvandraat, KPM van Galen, BAP Laros‐Van Gorkom, K Meijer, ... American journal of hematology 94 (8), E201-E205, 2019 | 19 | 2019 |
| Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals F Atiq, E Hameli, AEC Broers, JK Doorduijn, T Van Gelder, LM Andrews, ... European journal of clinical pharmacology 74, 767-773, 2018 | 18 | 2018 |
| Importance of genotyping in von Willebrand disease to elucidate pathogenic mechanisms and variability in phenotype F Atiq, J Boender, WL Van Heerde, JMT Garcia, SC Schoormans, ... HemaSphere 6 (6), e718, 2022 | 17 | 2022 |
| Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies F Atiq, R Blok, CB van Kwawegen, D Doherty, M Lavin, JG van der Bom, ... Blood 143 (14), 1414-1424, 2024 | 14 | 2024 |
| Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease F Atiq, J Heijdra, F Snijders, J Boender, E Kempers, WL van Heerde, ... Blood advances 6 (18), 5317-5326, 2022 | 12 | 2022 |
| von Willebrand factor multimer densitometric analysis: validation of the clinical accuracy and clinical implications in von Willebrand disease J Boender, F Atiq, MH Cnossen, JG Van Der Bom, K Fijnvandraat, ... Hemasphere 5 (3), e542, 2021 | 11 | 2021 |
| Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding F Atiq, E Wuijster, MPM de Maat, MJHA Kruip, MH Cnossen, ... Journal of Thrombosis and Haemostasis 19 (3), 719-731, 2021 | 11 | 2021 |
| Von Willebrand disease type 2M: correlation between genotype and phenotype DP Maas, F Atiq, NMA Blijlevens, PPT Brons, S Krouwel, ... Journal of Thrombosis and Haemostasis 20 (2), 316-327, 2022 | 10 | 2022 |
| Quantitative 3D microscopy highlights altered von Willebrand factor α‐granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms M Swinkels, F Atiq, PE Bürgisser, JA Slotman, AB Houtsmuller, C de Heus, ... Research and Practice in Thrombosis and Haemostasis 5 (6), e12595, 2021 | 10 | 2021 |